Ping Xue

3.6k total citations · 1 hit paper
51 papers, 2.8k citations indexed

About

Ping Xue is a scholar working on Molecular Biology, Cancer Research and Cellular and Molecular Neuroscience. According to data from OpenAlex, Ping Xue has authored 51 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 15 papers in Cancer Research and 7 papers in Cellular and Molecular Neuroscience. Recurrent topics in Ping Xue's work include Cancer-related molecular mechanisms research (9 papers), MicroRNA in disease regulation (8 papers) and Circular RNAs in diseases (8 papers). Ping Xue is often cited by papers focused on Cancer-related molecular mechanisms research (9 papers), MicroRNA in disease regulation (8 papers) and Circular RNAs in diseases (8 papers). Ping Xue collaborates with scholars based in China, United States and France. Ping Xue's co-authors include Liangqi Cao, Han Zhang, Xiaofeng Jiang, Zhongjian Xie, Xuewei Yang, Taojian Fan, Tingting Zheng, Yun Chen, Xiaoling Luo and Jianming Chen and has published in prestigious journals such as PLoS ONE, Biomaterials and Annals of Neurology.

In The Last Decade

Ping Xue

50 papers receiving 2.8k citations

Hit Papers

Advances in nanomaterials for photodynamic therapy applic... 2020 2026 2022 2024 2020 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ping Xue China 24 1.1k 686 685 507 474 51 2.8k
Ke Xu China 38 2.1k 2.0× 540 0.8× 1.1k 1.7× 110 0.2× 215 0.5× 145 4.2k
Ljubica Harhaji‐Trajkovic Serbia 29 1.2k 1.1× 989 1.4× 269 0.4× 138 0.3× 145 0.3× 61 3.5k
Yunxiang Zhou China 20 784 0.7× 468 0.7× 222 0.3× 177 0.3× 76 0.2× 43 2.1k
Yongchuan Deng China 24 914 0.9× 498 0.7× 427 0.6× 146 0.3× 54 0.1× 53 2.4k
Vladimir V. Shuvaev United States 37 1.5k 1.4× 523 0.8× 239 0.3× 151 0.3× 69 0.1× 74 3.6k
Qiwei Yang China 28 1.9k 1.8× 456 0.7× 1.0k 1.5× 123 0.2× 71 0.1× 111 3.3k
Peng Zhao China 33 1.5k 1.4× 535 0.8× 513 0.7× 115 0.2× 70 0.1× 97 3.4k
Michael Höpfner Germany 29 1.2k 1.1× 253 0.4× 384 0.6× 109 0.2× 139 0.3× 64 2.5k
Colin E. Evans United States 27 1.0k 1.0× 236 0.3× 611 0.9× 275 0.5× 79 0.2× 61 3.1k
Xiaomei Yang China 37 2.0k 1.9× 215 0.3× 969 1.4× 73 0.1× 137 0.3× 111 3.6k

Countries citing papers authored by Ping Xue

Since Specialization
Citations

This map shows the geographic impact of Ping Xue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ping Xue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ping Xue more than expected).

Fields of papers citing papers by Ping Xue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ping Xue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ping Xue. The network helps show where Ping Xue may publish in the future.

Co-authorship network of co-authors of Ping Xue

This figure shows the co-authorship network connecting the top 25 collaborators of Ping Xue. A scholar is included among the top collaborators of Ping Xue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ping Xue. Ping Xue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Songjie, Han Chen, Ping Xue, et al.. (2024). Tailoring biomaterials for skin anti-aging. Materials Today Bio. 28. 101210–101210. 10 indexed citations
2.
Xue, Ping, et al.. (2024). Surgical Efficacy Analysis of Traumatic Posterior Fossa Epidural Hematoma in Children. World Neurosurgery. 194. 123454–123454. 1 indexed citations
3.
Chen, Shaoyi, Zongyan Li, Shiying Li, et al.. (2022). Tumor-associated macrophages promote cholangiocarcinoma progression via exosomal Circ_0020256. Cell Death and Disease. 13(1). 94–94. 57 indexed citations
4.
Liu, Zhaoyuan, Zhongjian Xie, Wenting Li, et al.. (2021). Photodynamic immunotherapy of cancers based on nanotechnology: recent advances and future challenges. Journal of Nanobiotechnology. 19(1). 160–160. 89 indexed citations
5.
Xue, Ping, Yuanfeng Zhou, Shi Wei, et al.. (2021). Optimized SEEG-guided radiofrequency thermocoagulation in the treatment of pediatric hypothalamic hamartomas. Seizure. 86. 102–108. 18 indexed citations
6.
Liu, Zhaoyuan, Zhongjian Xie, Xinqiang Wu, et al.. (2021). pH-responsive black phosphorus quantum dots for tumor-targeted photodynamic therapy. Photodiagnosis and Photodynamic Therapy. 35. 102429–102429. 11 indexed citations
7.
Xue, Ping, Saihua Huang, Xiao Han, et al.. (2021). Exosomal miR-101-3p and miR-423-5p inhibit medulloblastoma tumorigenesis through targeting FOXP4 and EZH2. Cell Death and Differentiation. 29(1). 82–95. 58 indexed citations
8.
Luo, Zaili, Xinran Dong, Jianzhong Yu, et al.. (2021). Genomic and Transcriptomic Analyses Reveals ZNF124 as a Critical Regulator in Highly Aggressive Medulloblastomas. Frontiers in Cell and Developmental Biology. 9. 634056–634056. 11 indexed citations
9.
Zhang, Dawei, Zongyan Li, Haiyan Li, et al.. (2021). Photosensitizer IR700DX-6T- and IR700DX-mbc94-mediated photodynamic therapy markedly elicits anticancer immune responses during treatment of pancreatic cancer. Pharmacological Research. 172. 105811–105811. 8 indexed citations
12.
Fu, Jinrong, Xia Li, Ching‐Hsiung Lin, et al.. (2019). Particulate matter of 2.5 μm or less in diameter disturbs the balance of TH17/regulatory T cells by targeting glutamate oxaloacetate transaminase 1 and hypoxia-inducible factor 1α in an asthma model. Journal of Allergy and Clinical Immunology. 145(1). 402–414. 88 indexed citations
13.
Cao, Liangqi, Xuewei Yang, Yubin Chen, et al.. (2019). Exosomal miR-21 regulates the TETs/PTENp1/PTEN pathway to promote hepatocellular carcinoma growth. Molecular Cancer. 18(1). 148–148. 146 indexed citations
14.
Dong, Rui, Deshui Jia, Ping Xue, et al.. (2014). Genome-Wide Analysis of Long Noncoding RNA (lncRNA) Expression in Hepatoblastoma Tissues. PLoS ONE. 9(1). e85599–e85599. 71 indexed citations
15.
Zhang, Dawei, et al.. (2013). Expression of glioma-associated oncogene 2 (Gli 2) is correlated with poor prognosis in patients with hepatocellular carcinoma undergoing hepatectomy. World Journal of Surgical Oncology. 11(1). 25–25. 30 indexed citations
16.
Xue, Ping. (2012). Antioxidation of Different Extracts from Isatidis indigotica in vitro. Zhongguo shiyan fangjixue zazhi. 4 indexed citations
17.
Yang, Xuewei, Xiaoli Wang, Xiaofeng Jiang, et al.. (2012). Green tea polyphenol epigallocatechin‐3‐gallate enhances 5‐fluorouracil‐induced cell growth inhibition of hepatocellular carcinoma cells. Hepatology Research. 42(5). 494–501. 39 indexed citations
18.
Bi, Wei, Yue Bi, Ping Xue, et al.. (2011). Novel β-carboline-tripeptide conjugates attenuate mesenteric ischemia/reperfusion injury in the rat. European Journal of Medicinal Chemistry. 46(6). 2441–2452. 13 indexed citations
19.
Bi, Wei, Yue Bi, Ping Xue, et al.. (2011). A new class of β-carboline alkaloid-peptide conjugates with therapeutic efficacy in acute limb ischemia/reperfusion injury. European Journal of Medicinal Chemistry. 46(5). 1453–1462. 19 indexed citations
20.
Cao, Liangqi, Xiaoli Wang, Qian Wang, et al.. (2009). Rosiglitazone sensitizes hepatocellular carcinoma cell lines to 5-fluorouracil antitumor activity through activation of the PPARγ signaling pathway. Acta Pharmacologica Sinica. 30(9). 1316–1322. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026